Yatharth Hospital
683.70
-4.40(-0.64%)
Market Cap₹- Cr
PE Ratio-
Company Performance:
1D-0.64%
1M-16.79%
6M+34.67%
1Y+10.75%
5Y+104.79%
View Company Insightsright
More news about Yatharth Hospital
06Nov 25
Yatharth Hospital's Credit Rating Upgraded to CRISIL A/Stable
CRISIL Ratings Limited has upgraded Yatharth Hospital & Trauma Care Services Limited's corporate credit rating from 'CRISIL A-/Stable' to 'CRISIL A/Stable'. The upgrade, communicated on November 6, 2025, signifies an improved credit profile with low credit risk and adequate safety for timely servicing of financial obligations. This enhancement may lead to better credibility with lenders, potentially more favorable borrowing terms, and improved financial flexibility for the multi-location hospital chain operating in Noida, Greater Noida, Faridabad, New Delhi, and Madhya Pradesh.
05Nov 25
Yatharth Hospital Appoints Healthcare Veteran Ramesh Krishnan as Independent Director
Yatharth Hospital and Trauma Care Services Limited has appointed Mr. Ramesh Krishnan as an Additional Director (Non-Executive Independent) for a five-year term from November 05, 2025, to November 04, 2030, subject to shareholder approval. Krishnan brings over three decades of healthcare industry experience, having held leadership positions at Relia Institute, Everstone Capital, Parkway Pantai, and Fortis Healthcare. The appointment complies with regulatory requirements, and Krishnan is not related to any existing directors, ensuring his independence.
01Nov 25
Yatharth Hospital's Subsidiary Launches Operations in Faridabad, Expanding Healthcare Portfolio
Yatharth Hospital & Trauma Care Services Limited's subsidiary, MGS Infotech Research and Solutions Private Limited, has begun operations at a new hospital in Sector 20, Faridabad, Haryana, effective November 1, 2025. This strategic expansion aims to broaden the company's healthcare portfolio, enhance its presence in the National Capital Region (NCR), and strengthen its position in the healthcare sector. While specific financial projections were not disclosed, the company expects this new facility to provide additional revenue streams and contribute to long-term business goals. The expansion could potentially increase Yatharth Hospital's market share in the region and enhance its competitive position in the healthcare industry.
14Oct 25
Kedia Securities Acquires 1% Stake in Yatharth Hospital
Kedia Securities Private Limited has acquired a 1% stake in Yatharth Hospital during the second quarter. This strategic investment marks Kedia Securities' entry into the healthcare sector, potentially signaling confidence in Yatharth Hospital's future prospects and the overall healthcare industry growth. The financial terms of the deal have not been disclosed.
08Oct 25
Yatharth Hospital Stock Soars to All-Time High on Revised CGHS Rates
Yatharth Hospital & Trauma Care Services' stock hit an all-time high of ₹839.00, surging over 10% following the Union Health Ministry's announcement of revised rates for nearly 2,000 medical procedures under the Central Government Health Services (CGHS) scheme. The new multi-layered rate structure, effective from October 13, offers different compensation rates based on hospital accreditation and type. Yatharth Hospital's recent quarterly results showed a 40% increase in net profit to ₹42.00 crore and a 22% increase in revenue to ₹258.00 crore. The stock has gained over 55% in the past year.
13Sept 25
Yatharth Hospital Expands Footprint with Rs. 260 Crore Acquisition in Agra
Yatharth Hospital and Trauma Care Services Limited has approved the acquisition of a 100% stake in Shantived Institute of Medical Sciences (SVIMS), a super-specialty hospital in Agra, for an enterprise value of Rs. 260.00 crores. SVIMS has a current capacity of 150 beds, expandable to 250 beds, and is spread across 1,65,000 square feet. The cash transaction is expected to complete within 3 months and requires no regulatory approvals. This strategic move aims to expand Yatharth Hospital's presence in Uttar Pradesh and strengthen its market position in the healthcare sector.
13Aug 25
Yatharth Hospital Reports 22% Revenue Growth and 38% Net Profit Surge in Q1 FY26
Yatharth Hospital & Trauma Care Services Limited reported impressive Q1 FY26 results. Revenue increased 22% year-on-year to Rs. 2,578.00 million, while net profit surged 38% to Rs. 420.00 million. EBITDA grew 20% to Rs. 645.00 million with a 25% margin. The Greater Faridabad facility turned profitable within a year, contributing 9% to total revenue. Inpatient and outpatient volumes increased significantly. The company inaugurated a New Delhi facility in July 2025 and plans to launch a Faridabad facility in August 2025, adding approximately 700 beds. Management expects to maintain 30% revenue growth and similar EBITDA margins.
12Aug 25
Yatharth Hospital Reports Rs 4,593.37 Million QIP Proceeds Utilization
Yatharth Hospital has utilized Rs 4,593.37 million out of Rs 6,039.00 million net proceeds from its QIP. Funds were used for debt repayment (Rs 956.80 million), hospital acquisitions (Rs 2,163.17 million), medical equipment (Rs 400.56 million), and general corporate purposes (Rs 1,072.83 million). The company launched a new hospital in Delhi. Remaining funds of Rs 1,445.64 million are invested in fixed deposits, mutual funds, and bank balances. Future plans include purchasing medical equipment and meeting corporate expenses.
11Aug 25
Yatharth Hospital to Join MSCI India Small Cap Index, Boosting Global Visibility
Yatharth Hospital and Trauma Care Services Ltd will be included in the MSCI India Small Cap Index on August 26, 2025. The company operates seven super specialty hospitals across North India with over 2,300 beds. It has shown strong financial growth with a 40% CAGR in revenue and 61% CAGR in PAT over the past four years. The index inclusion is expected to increase the company's visibility among global investors.
05Aug 25
Yatharth Hospital Reports Strong Q1 FY2026 Growth Amid Auditor Resignations
Yatharth Hospital & Trauma Care Services Limited reported robust Q1 FY2026 results with 22% YoY growth in Operating Revenue to Rs. 2,578.00 million, 20% YoY increase in EBITDA to Rs. 645.00 million, and 40% YoY surge in PAT to Rs. 425.00 million. The company saw operational improvements with increased bed occupancy and ARPOB. Two new facilities in New Delhi and Faridabad are set to boost growth. However, the company's statutory auditors resigned citing inadequate remuneration for the required audit efforts.
05Aug 25
Yatharth Hospital Reports Strong Q1 Results, Makes Key Auditor Appointments
Yatharth Hospital & Trauma Care Services Ltd reported robust Q1 financial performance with consolidated revenue of ₹2,577.71 million and net profit of ₹303.84 million. The company made several key appointments, including M/s MKP & Associates as Secretarial Auditor and M/s Subodh Kumar & Co. as Cost Auditor. Yatharth Hospital also inaugurated its Delhi facility, commencing commercial operations.
17Jul 25
Mukul Agrawal Acquires 1.14% Stake in Yatharth Hospital
Renowned investor Mukul Agrawal has disclosed a 1.14% stake in Yatharth Hospital, a prominent healthcare provider. This information was revealed in the company's latest shareholding pattern report for the first quarter. The entry of a well-known investor like Agrawal could be interpreted as a positive signal for the company's prospects and may attract attention from other market participants.
14Jul 25
Yatharth Hospitals Expands Footprint with New Super-Specialty Facility in New Delhi
Yatharth Hospital and Trauma Care Services Limited has opened a new 300-bed super-specialty hospital in Model Town, New Delhi. The facility, built on two acres, includes 70 critical care beds and offers advanced services in cardiology, oncology, orthopaedics, neurology, and nephrology. This expansion increases Yatharth Hospitals' total capacity to over 2,300 beds across seven super-specialty hospitals. The inauguration was attended by Delhi's Chief Minister and local legislators, highlighting the hospital's contribution to the city's healthcare infrastructure.
03Jul 25
Yatharth Hospital Bolsters Leadership Team with New Group Chief for Strategy, M&A, and Investor Relations
Yatharth Hospital has appointed Ashutosh Kumar Jha as the new Group Chief for Strategy, M&A, and Investor Relations. Jha brings extensive experience from his previous role as Director and Head of Growth at Max Healthcare, as well as from his time at The Bosch Group and Maruti Suzuki. This appointment aims to strengthen Yatharth Hospital's strategic planning, M&A activities, and investor relations.
28May 25
Yatharth Hospital Unveils Rs 310 Crore Capex Plan for Expansion
Yatharth Hospital has announced a Rs 310 crore capital expenditure plan for this year, focusing on brownfield expansion in the NCR region. The company plans to add 200 beds to its Greater Noida facility and 250 beds to its Noida Extension hospital. Additionally, Yatharth is in talks with health ministries in Iraq and Congo for potential international partnerships. The company expects its new facilities to face initial EBITDA losses for 12-15 months before breaking even, with projections for the new Jhansi facility's ARPOB set at Rs 13,000 to Rs 15,000.
26May 25
Yatharth Hospital Expands Capacity with Two New Acquisitions
Yatharth Hospital & Trauma Care Services has acquired two new hospitals, set to increase its bed capacity by 300-400. The company plans to make these facilities operational in Q1FY26, marking a significant expansion of its healthcare services.
26May 25
Yatharth Hospital Q4 Results: Revenue Surges, EBITDA Grows, Margin Dips
Yatharth Hospital & Trauma Care Services posted a 29.94% year-over-year revenue increase to ₹230.00 crore in Q4. EBITDA rose 22.58% to ₹57.00 crore, but EBITDA margin declined to 24.78% from 26.27%. Net profit showed marginal growth of 1.04% to ₹38.70 crore. The results indicate robust top-line expansion but challenges in maintaining profitability amid growth.
Yatharth Hospital
683.70
-4.40
(-0.64%)
1 Year Returns:+10.75%
Industry Peers
Yatharth Hospital
683.70
(-0.64%)
Unihealth Hospitals
293.50
(-5.00%)
Nephro Care
128.70
(+0.08%)
Narayana Hrudayalaya
1,937.60
(-0.90%)
Apollo Hospitals
7,201.00
(+0.24%)
Maitreya Medicare
253.65
(+2.48%)
Global Health
1,200.80
(-0.96%)
GPT Healthcare
141.00
(+0.68%)
Shalby
200.64
(-1.59%)